Patient Preferences for Treatment of Psoriasis with Biologicals: A Discrete Choice Experiment

Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris

(2014) R. Gniadecki et al.   BRITISH JOURNAL OF DERMATOLOGY

Elicitation and Use of Patients’ Preferences in the Treatment of Psoriasis: A Systematic Review

(2013) N Umar et al.   ACTA DERMATO-VENEREOLOGICA

Satisfaction with treatment among patients with psoriasis: a web-based survey study

(2013) O.D. van Cranenburgh et al.   BRITISH JOURNAL OF DERMATOLOGY

Which Antipsoriatic Drug Has the Fastest Onset of Action?—Systematic Review on the Rapidity of the Onset of Action

(2013) Alexander Nast et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

(2013) Iain B McInnes et al.   LANCET

The framing effect in medical decision-making: a review of the literature

(2013) Jingjing Gong et al.   Psychology Health & Medicine

Undertreatment, Treatment Trends, and Treatment Dissatisfaction Among Patients With Psoriasis and Psoriatic Arthritis in the United States

(2013) April W. Armstrong et al.   JAMA Dermatology

S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update

(2012) Alexander Nast et al.   JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Patient preferences for psoriasis treatments: impact of treatment experience

(2012) M.-L. Schaarschmidt et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Matching physicians’ treatment recommendations to patients’ treatment preferences is associated with improvement in treatment satisfaction

(2012) N. Umar et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis

(2011) Zoe Ash et al.   ANNALS OF THE RHEUMATIC DISEASES

Patient Preferences for Psoriasis Treatments

(2011) Marthe-Lisa Schaarschmidt   ARCHIVES OF DERMATOLOGY

Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials

(2011) K. Reich et al.   BRITISH JOURNAL OF DERMATOLOGY

Adherence in the Treatment of Psoriasis: A Systematic Review

(2011) M. Augustin et al.   DERMATOLOGY

Physical and Mental Impact of Psoriasis Severity as Measured by the Compact Short Form-12 Health Survey (SF-12) Quality of Life Tool

(2011) Ivan Grozdev et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Comorbidities significantly impact patients’ preferences for psoriasis treatments

(2011) Astrid Schmieder et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis

(2011) Alexa Boer Kimball et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Patient satisfaction with injection devices: a randomized controlled study comparing two different etanercept delivery systems in moderate to severe psoriasis

(2011) C. Paul et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Safety of treatment with biologics for psoriasis in daily practice: 5-year data

(2011) P.P.M. van Lümig et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Time Needed for Treatment Is the Major Predictor of Quality of Life in Psoriasis

(2010) Christine Blome et al.   DERMATOLOGY

Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials

(2008) J. Schmitt et al.   BRITISH JOURNAL OF DERMATOLOGY

Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis

(2008) Kristian Reich et al.   CURRENT MEDICAL RESEARCH AND OPINION

Guidelines of care for the management of psoriasis and psoriatic arthritis

(2008) Alan Menter et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

(2008) Craig L Leonardi et al.   LANCET